Valuation
OZPHOzone Pharmaceuticals
StockMoscow ExchangeロシアHealth care
7/10
Ratios vs sector
Medians of Health care companies worldwide (too few in the region).
| Metric | OZPH | Sector median | vs median |
|---|---|---|---|
| P/E | — | 28.5 · n=122 | — |
| P/B | — | 3.0 · n=210 | — |
| P/S | — | 3.7 · n=213 | — |
| EV/EBIT | — | 23.8 · n=110 | — |
| Free-cash-flow yield | — | 2.8% · n=199 | — |
| Dividend yield | 2.84% | 0.00% · n=282 | — |
| Return on equity | — | 2.7% · n=207 | — |
| Return on invested capital | — | 3.7% · n=187 | — |
| Gross margin | — | 62.5% · n=160 | — |
| Net debt / EBITDA | — | 1.14 · n=112 | — |
Value factor: 39 of 100 within the peer group. Full score breakdown →
Sector peers
The largest companies of the same sector and region.
| Instrument | P/E | P/B | EV/EBIT | Free-cash-flow yield | Dividend yield | Smart Score |
|---|---|---|---|---|---|---|
| LLYEli Lilly & Co | 42.6 | 33.6 | — | 1.6% | 0.6% | 6/10 |
| JNJJohnson & Johnson | 29.1 | 7.2 | — | 3.6% | 2.1% | 8/10 |
| ABBVAbbVie | 79.9 | — | 33.5 | 3.6% | 3.0% | 5/10 |
| MRKMerck | 114.6 | 8.7 | — | 4.4% | 2.3% | 8/10 |
| UNHUnitedHealth | 25.1 | 3.4 | 18.6 | 6.7% | 2.3% | 9/10 |
| NVSNovartis AG | 20.0 | 6.1 | 16.9 | 6.3% | 3.2% | 10/10 |
| TMOThermo Fisher Scientific | 35.7 | 4.7 | 35.2 | 2.9% | 0.3% | 8/10 |
| AMGNAmgen | 26.3 | 19.7 | 24.0 | 4.4% | 2.3% | 6/10 |
| GILDGILEAD | — | 16.1 | — | 6.8% | 2.1% | 4/10 |
| ABTAbbott | 28.5 | 3.4 | 26.8 | 4.1% | 3.0% | 5/10 |
ratios computed by AI-Stock Invest from public filings and end-of-day prices
ここで契約を解約する · EU消費者向け：購入から14日以内の返品が可能。